Targeted 'radioligand' improves survival in advanced prostate cancer

(Oregon Health& Science University) A new kind of prostate cancer treatment tested at Oregon Health& Science University combines a targeting compound with a radioactive isotope to irradiate and kill cancer cells, sparing most normal tissues.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news